| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.02 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.16 | 0.02 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |